Interdisciplinary Perioperative Care in Minimally-invasive Heart Valve Surgery (INCREASE)

December 8, 2024 updated by: Evaldas Girdauskas, Universitätsklinikum Hamburg-Eppendorf

Interdisciplinary and Cross-sectoral Perioperative Care Model in the Cardiac Surgery: Implementation in the Setting of Minimally-invasive Heart Valve Surgery (INCREASE)

Valvular heart diseases are among the most common cardiac pathologies in adult patients in Germany. Currently, the process of care before, during and after heart valve surgery does not follow a standardized and interdisciplinary optimal approach. An approach already established in other surgical disciplines is the Enhanced Recovery After Surgery (ERAS) protocol, which aims at optimizing the recovery process of patients. Within the INCREASE study, a care process inspired by the ERAS protocol will be established at the University Heart and Vascular Center (UHZ) of the University Medical Center Hamburg-Eppendorf (UKE) and the University Medical Center Augsburg (UKA). Executing the study at two facilities in different regions in Germany will help to demonstrate transferability of the process of care. The effectiveness of this process compared to the current treatment approach will be investigated in a randomized controlled trial. A total of 186 patients will be allocated by chance either to the intervention group (ERAS protocol) or the control group (treatment as usual). Patients in the intervention group will receive an optimized interdisciplinary care protocol including medical, nursing, physiotherapeutical and psychotherapeutical interventions. Measurements of effectiveness are the number of hospitalized days (due to cardiac causes) within one year and the physical condition of the patient as measured by the 6-minute walk test (6MWT) on the day of discharge.

Study Overview

Study Type

Interventional

Enrollment (Actual)

201

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Hamburg, Germany, 20246
        • Universitätsklinikum Hamburg-Eppendorf
    • Bavaria
      • Augsburg, Bavaria, Germany, 86156
        • Universitätsklinikum Augsburg

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Indication for elective minimally invasive (open) aortic or mitral valve surgery
  • Patient's ability to understand the nature and extent of the individual's requirements for participation in the new care setting
  • Classification of the patient as "FIT" or "Pre-FRAIL" using the LUCAS functional index (frailty index) (Dapp et al. 2012)

Exclusion Criteria:

  • Limited life expectancy less than one year (e.g., advanced tumor disease)
  • Urgent or emergency interventions
  • Severe chronic obstructive pulmonary disease (GOLD III or IV)
  • Dialysis-dependant renal failure
  • Advanced liver cirrhosis (Child stages B + C)
  • Severe comorbidities or psychosocial reasons that militate against participation or do not allow for written informed consent (e. g., residual neurological impairment after prior stroke, major restrictions of mobility, neuropsychological disorders, depressive disorder, substance-related addictive disorders)
  • Lack of a social environment that can provide supportive patient care
  • Previous cardiac surgery (i.e., relative contraindication for minimally invasive technique)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: ERAS protocol (intervention group)
The innovative care process in the intervention group is characterized by an interdisciplinary approach according to the previously established enhanced recovery after surgery protocol. This process aims at improving the clinical outcome after cardiac surgery, increasing patient satisfaction and quality of life, enabling early professional reentry and participation, and optimizing the cost-effectiveness of service provision. In addition, intersectoral barriers are being broken down in order to establish an interdisciplinary and cross-sectoral overall care process for patients with heart valve surgery as a new form of care in the future.
Enhanced recovery after surgery is a multimodal, transdisciplinary care approach for patients undergoing surgical procedures. It is implemented in various surgical specialties, among others in cardiac surgery. The care approach aims at promotion of recovery of the patients throughout their perioperative process, reduction of complications, and early return to normal activities.
Other Names:
  • ERAS
  • fast track
  • rapid recovery
Active Comparator: Treatment as usual (control group)
The control group undergoes standard heart valve surgery. In this case, no preoperative interventions take place, the patient is operated on the affected heart valve in a minimally invasive procedure without prehabilitation. After surgery, the patient is transfered to an intensive care unit (not a specialized postanesthesia care unit) depending on the individual condition and then transfered to the general ward. Patients receive medical, nursing, and physiotherapeutic care in accordance with current hospital standards.
treatment as usual according to standard care in heart valve surgery

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Hospitalization
Time Frame: twelve months
number of hospitalized days due to cardiac reasons
twelve months
Six Minute Walk Test
Time Frame: day of discharge (approx. 5 - 10 days after operation)
physical capacity expressed with the walking distance in meters
day of discharge (approx. 5 - 10 days after operation)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Goal Attainment Scale (GAS)
Time Frame: three months
level of attainment of individual goal: +2 = much more than expected, +1 = somewhat more than expected, 0 = goal achieved than expected, -1 = somewhat less than expected, -2 = much less than expected
three months
Goal Attainment Scale (GAS)
Time Frame: twelve months
level of attainment of individual goal: +2 = much more than expected, +1 = somewhat more than expected, 0 = goal achieved than expected, -1 = somewhat less than expected, -2 = much less than expected
twelve months
HeartQoL
Time Frame: three months
health-related quality of life; 14 items, min 0, max 42, higher scores indicating better health-related quality of life
three months
HeartQoL
Time Frame: twelve months
health-related quality of life; 14 items, min 0, max 42, higher scores indicating better health-related quality of life
twelve months
Costs
Time Frame: up to 10 days
direct costs in € associated with the operative procedure and the initial hospitalization using diagnosis related groups as classification system, in which diagnoses and treatments are valued according to their necessary economical expenditure
up to 10 days

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
European Health Literacy Questionnaire (HLS-EU-Q16)
Time Frame: day of discharge (approx. 5 - 10 days after operation)
health literacy: 16 items, min 16, max 64, higher scores indicating lower health literacy
day of discharge (approx. 5 - 10 days after operation)
European Health Literacy Questionnaire (HLS-EU-Q16)
Time Frame: twelve months
health literacy: 16 items, min 16, max 64, higher scores indicating lower health literacy
twelve months
Brief Illnness Perception Questionnaire (BIPQ)
Time Frame: day of discharge (approx. 5 - 10 days after operation)
individual concept of illness; 8 items, min 0, max 80, higher scores indicating worse illness perception
day of discharge (approx. 5 - 10 days after operation)
Brief Illnness Perception Questionnaire (BIPQ)
Time Frame: twelve months
individual concept of illness; 8 items, min 0, max 80, higher scores indicating worse illness perception
twelve months
Treatment Expectation Questionnaire (TEX-Q)
Time Frame: day of discharge (approx. 5 - 10 days after operation)
treatment expectations; 15 items, min 0, max 150, higher scores indicating higher expectations of effects of the treatment
day of discharge (approx. 5 - 10 days after operation)
Treatment Expectation Questionnaire (TEX-Q)
Time Frame: three months
treatment expectations; 15 items, min 0, max 150, higher scores indicating higher expectations of effects of the treatment
three months
Treatment Expectation Questionnaire (TEX-Q)
Time Frame: twelve months
treatment expectations; 15 items, min 0, max 150, higher scores indicating higher expectations of effects of the treatment
twelve months
Patient Health Questionnaire-9 (PHQ-9)
Time Frame: day of discharge (approx. 5 - 10 days after operation)
depressive symptoms; 9 items, min 0, max 27, higher scores indicating higher depressive symptoms
day of discharge (approx. 5 - 10 days after operation)
Patient Health Questionnaire-9 (PHQ-9)
Time Frame: three months
depressive symptoms; 9 items, min 0, max 27, higher scores indicating higher depressive symptoms
three months
Patient Health Questionnaire-9 (PHQ-9)
Time Frame: twelve months
depressive symptoms; 9 items, min 0, max 27, higher scores indicating higher depressive symptoms
twelve months
Generalized Anxiety Disorder-2 (GAD-2)
Time Frame: day of discharge (approx. 5 - 10 days after operation)
anxiety symptoms; 2 items, min 0, max 6, higher scores indicating higher anxiety symptoms
day of discharge (approx. 5 - 10 days after operation)
Generalized Anxiety Disorder-2 (GAD-2)
Time Frame: three months
anxiety symptoms; 2 items, min 0, max 6, higher scores indicating higher anxiety symptoms
three months
Generalized Anxiety Disorder-2 (GAD-2)
Time Frame: twelve months
anxiety symptoms; 2 items, min 0, max 6, higher scores indicating higher anxiety symptoms
twelve months
Cardiac Anxiety Questionnaire (CAQ)
Time Frame: day of discharge (approx. 5 - 10 days after operation)
cardiac anxiety; 17 items, min 0, max 68, higher scores indicating higher cardiac anxiety
day of discharge (approx. 5 - 10 days after operation)
Cardiac Anxiety Questionnaire (CAQ)
Time Frame: three months
cardiac anxiety; 17 items, min 0, max 68, higher scores indicating higher cardiac anxiety
three months
Cardiac Anxiety Questionnaire (CAQ)
Time Frame: twelve months
cardiac anxiety; 17 items, min 0, max 68, higher scores indicating higher cardiac anxiety
twelve months
Life Orientation Test - revised (LOT-R)
Time Frame: day of discharge (approx. 5 - 10 days after operation)
optimism; 10 items, min 0, max 24, higher scores indicating higher optimism
day of discharge (approx. 5 - 10 days after operation)
Somatic Symptom Scale-8 (SSS-8)
Time Frame: day of discharge (approx. 5 - 10 days after operation)
somatic symptom burden; 8 items, min 0, max 32, higher scores indicating higher somatic symptom burden
day of discharge (approx. 5 - 10 days after operation)
Somatic Symptom Scale-8 (SSS-8)
Time Frame: three months
somatic symptom burden; 8 items, min 0, max 32, higher scores indicating higher somatic symptom burden
three months
Somatic Symptom Scale-8 (SSS-8)
Time Frame: twelve months
somatic symptom burden; 8 items, min 0, max 32, higher scores indicating higher somatic symptom burden
twelve months
Somatic Symptom Disorder - B Criteria Scale (SSD-12)
Time Frame: day of discharge (approx. 5 - 10 days after operation)
coping with somatic symptoms; 12 items, min 0, max 48, higher scores indicating worse coping with somatic symptoms
day of discharge (approx. 5 - 10 days after operation)
Somatic Symptom Disorder - B Criteria Scale (SSD-12)
Time Frame: three months
coping with somatic symptoms; 12 items, min 0, max 48, higher scores indicating worse coping with somatic symptoms
three months
Somatic Symptom Disorder - B Criteria Scale (SSD-12)
Time Frame: twelve months
coping with somatic symptoms; 12 items, min 0, max 48, higher scores indicating worse coping with somatic symptoms
twelve months
International Physical Activity Questionnaire Short Form (IPAQ)
Time Frame: day of discharge (approx. 5 - 10 days after operation)
level of physical activity
day of discharge (approx. 5 - 10 days after operation)
International Physical Activity Questionnaire Short Form (IPAQ)
Time Frame: twelve months
level of physical activity
twelve months
Hand Dynamometer
Time Frame: day of discharge (approx. 5 - 10 days after operation)
hand grip strength
day of discharge (approx. 5 - 10 days after operation)
Hand Dynamometer
Time Frame: twelve months
hand grip strength
twelve months
1 Minute Sit to Stand Test (1STS)
Time Frame: day of discharge (approx. 5 - 10 days after operation)
physical capacity expressed with the number of repetitions
day of discharge (approx. 5 - 10 days after operation)
1 Minute Sit to Stand Test (1STS)
Time Frame: twelve months
physical capacity expressed with the number of repetitions
twelve months
Timed Up and Go (TUG)
Time Frame: day of discharge (approx. 5 - 10 days after operation)
physical capacity expressed with the duration in seconds
day of discharge (approx. 5 - 10 days after operation)
Timed Up and Go (TUG)
Time Frame: twelve months
physical capacity expressed with the duration in seconds
twelve months
Six Minute Walk Test
Time Frame: twelve months
physical capacity expressed with the walking distance in meters
twelve months
Goal Attainment Scale (GAS)
Time Frame: day of discharge (approx. 5 - 10 days after operation)
level of attainment of individual goal: +2 = much more than expected, +1 = somewhat more than expected, 0 = goal achieved than expected, -1 = somewhat less than expected, -2 = much less than expected
day of discharge (approx. 5 - 10 days after operation)
Readiness for Hospital Discharge Scale (RHDS)
Time Frame: day of discharge (approx. 5 - 10 days after operation)
readiness for hospital discharge; 9 items, min 0, max 36, higher scores indicating higher readniss to discharge
day of discharge (approx. 5 - 10 days after operation)
5-level EQ-5D Health-related Quality of Life Questionnaire (EQ-5D-5L)
Time Frame: three months
health-related quality of life; 6 items, interpretation following an algorythm between 1 (best possible health condition) and <0 (worst possible health condition)
three months
5-level EQ-5D Health-related Quality of Life Questionnaire (EQ-5D-5L)
Time Frame: twelve months
health-related quality of life; 6 items, interpretation following an algorythm between 1 (best possible health condition) and <0 (worst possible health condition)
twelve months
Questionnaire for Health-Related Resource Use in an Elderly Population (FIMA)
Time Frame: twelve months
use of health care services; 11 items collecting numbers of health care services and days of usage, min 0, higher scores indicating higher usage of services
twelve months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Evaldas Girdauskas, Prof., Universitätsklinikum Hamburg-Eppendorf

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 1, 2021

Primary Completion (Actual)

March 24, 2024

Study Completion (Actual)

June 30, 2024

Study Registration Dates

First Submitted

June 18, 2021

First Submitted That Met QC Criteria

July 21, 2021

First Posted (Actual)

July 26, 2021

Study Record Updates

Last Update Posted (Estimated)

December 12, 2024

Last Update Submitted That Met QC Criteria

December 8, 2024

Last Verified

December 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Heart Valve Diseases

Clinical Trials on Enhanced Recovery After Surgery

Subscribe